Can an olfactory‑groove meningioma cause seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Olfactory Groove Meningioma Cause Seizures?

Yes, olfactory groove meningiomas can definitely cause seizures, with reported rates of approximately 78% in surgical series, making seizures one of the most common presenting symptoms of this tumor type 1, 2.

Seizure Risk in Meningiomas

Meningiomas are well-established causes of epilepsy, with more than one-third of all meningioma patients experiencing seizures at some point during their disease course 3. The evidence specifically documents that:

  • Seizures occur as a presenting symptom in 20-40% of brain tumor patients 4
  • In olfactory groove meningiomas specifically, seizures are reported in approximately 78% of cases 2
  • Seizures represent one of the most common clinical manifestations alongside headache, visual disturbances, personality changes, and anosmia 1, 5, 2

Key Predictive Factors

The likelihood of seizures in meningiomas is influenced by several factors 3:

  • Peritumoral edema (most significant predictor)
  • Non-skull base tumor location (olfactory groove meningiomas qualify as non-skull base)
  • Age <18 years
  • Male gender
  • Absence of headache as presenting symptom

Clinical Management Approach

If the Patient Has NOT Had a Seizure:

Do not prescribe prophylactic antiepileptic drugs (AEDs) - this is a Level A recommendation 4, 6. Primary anticonvulsant prophylaxis is not indicated in brain tumor patients, even with olfactory groove meningiomas, because:

  • Lack of efficacy in preventing first seizures
  • Significant side effects (cognitive impairment, neuropsychiatric disorders, fatigue, myelosuppression, drug interactions)
  • No evidence that tumor location, histology, or grade should influence this decision

If the Patient HAS Had a Seizure:

Start secondary seizure prophylaxis immediately 6. The vast majority of brain tumor patients who experience a seizure should be placed on anticonvulsant therapy, at least transiently.

First-line AED choice: Levetiracetam 6

  • Preferred at most neuro-oncology centers
  • Better side-effect profile than older agents
  • Caveat: psychiatric side effects can occur in some patients

Alternative first-line: Lamotrigine 6

  • Good antiseizure activity and tolerability
  • Requires several weeks to reach therapeutic levels (major limitation)

Avoid enzyme-inducing anticonvulsants (phenytoin, phenobarbital, carbamazepine) 6

  • Significant drug interactions with steroids and chemotherapy agents
  • Poor side-effect profile

Post-Surgical Management:

Approximately 70% of patients with preoperative seizures achieve seizure freedom after tumor resection 3. After successful surgery:

  • If near-gross total resection achieved: Attempt to taper and stop AEDs within weeks after surgery, provided no tumor recurrence 6
  • Monitor for new-onset postoperative seizures (occur in ~10% of patients without preoperative epilepsy) 3

Important Clinical Pitfalls

  1. Do not use tumor location as justification for prophylactic AEDs - there is insufficient evidence to support this practice, even for olfactory groove location 4

  2. New or worsening seizures often herald tumor progression - this should trigger repeat MRI and workup 6

  3. Consider EEG if altered mental status or vigilance problems - to rule out nonconvulsive status epilepticus 6

The evidence is clear and consistent across multiple 2021 guidelines: olfactory groove meningiomas can and do cause seizures frequently, but prophylactic treatment without a seizure history is not recommended due to lack of benefit and potential harm.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.